QILU PHARMACEUTICAL GROUP

Company Profile
QILU PHARMACEUTICAL GROUP
Qilu always commits itself to offering high-quality & trustworthy medicines to the world and improving people’s well-being. It is the first Chinese company to obtain both USFDA and EDQM approval for sterile APIs. Its Finished Formulations and APIs have been approved by USFDA, EMA, TGA, MHRA, PMDA, etc. Qilu maintains a robust and sustainable growth in global markets while consistently foraying into new geographies to further fortify its position globally. With a well-established domestic and overseas sales network, you may find Qilu’s footprints across the world.
more >

Year of Establishment: 1958

Total Assets(USD):

Total Number of Staff: more than 1000

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    QILU PHARMACEUTICAL GROUP
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service